Patents Assigned to TNI Pharmaceuticals, Inc.
  • Process for using endogenous enkephalins and endorphins to inhibit growth of tumerous cells
    Patent number: 4801614
    Abstract: A process for the therapeutic treatment of cancer patients involving stimulation and promotion of the natural immune system (both T cell and NK cell activity) resisting and inhibiting tumorous growth (cancer) as well as resisting infections (viral, bacterial and fungal) by administering an effective dosage (e.g., 0.25 mg per kilogram of body weight to as low as about 10.sup.-14 mg/kg) of an endogenous endorphin (e.g., leucine-enkephalin and methionine-enkephalin).
    Type: Grant
    Filed: October 1, 1987
    Date of Patent: January 31, 1989
    Assignee: TNI Pharmaceuticals, Inc.
    Inventor: Nicholas P. Plotnikoff
  • Process for using endogenous enkephalins and endorphins to stimulate the immune system of patients with aids
    Patent number: 4757049
    Abstract: A process for the therapeutic treatment of AIDS (acquired immune deficiency syndrome) involving stimulation and promotion of the natural immune system (both T cell and NK cell activity) resisting and inhibiting tumorous growth (cancer) as well as resisting infections (viral, bacterial and fungal) by administering an effective dosage (e.g., 0.25 mg per kilogram of body weight to as low as about 10.sup.-4 mg/kg) of an endogenous endorphin (e.g., leucine-enkephalin and methionine-enkephalin).
    Type: Grant
    Filed: October 20, 1986
    Date of Patent: July 12, 1988
    Assignee: TNI Pharmaceuticals, Inc.
    Inventor: Nicholas P. Plotnikoff
  • Process for using endogenous enkephalins and endorphins to stimulate the immune system
    Patent number: 4537878
    Abstract: A process of stimulating and promoting the natural immune system (T cells and NK cells) resisting and inhibiting the growth of tumorous cells as well as resisting infections (virus bacteria, and fungi) is disclosed. Endogenous endorphins are disclosed as the agent for stimulating the immune system.
    Type: Grant
    Filed: April 6, 1984
    Date of Patent: August 27, 1985
    Assignee: TNI Pharmaceuticals, Inc.
    Inventor: Nicholas P. Plotnikoff